Wednesday, Jun 7, 2023
English News
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
    • Rewind
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
  • Rewind
Home | Top Section | Bharath Biotech Refutes Charges Of Irregularities In Covaxin Supply To Brazil

Bharath Biotech refutes charges of irregularities in Covaxin supply to Brazil

This assertion came from Bharath Biotech, after Brazil indicated suspension of its contract with the Hyderabad-based vaccine maker after allegations of irregularities in the deal surfaced.

By Telangana Today
Published Date - 03:06 PM, Wed - 30 June 21
Bharath Biotech refutes charges of irregularities in Covaxin supply to Brazil
whatsapp facebook twitter telegram

Hyderabad: Bharath Biotech has refuted the reports that it resorted to irregularities in supply of its Covid-19 vaccine – Covaxin, to Brazil and asserted that the company had not digressed from any rules and regulations.

This assertion came from Bharath Biotech, after Brazil indicated suspension of its contract with the Hyderabad-based vaccine maker after allegations of irregularities in the deal surfaced.

Brazil’s President Jair Bolsonaro and Health Minister Marcelo Queiroga have also denied allegations of wrongdoing.

​Bharath Biotech reiterated that it had followed a step-by-step approach towards contracts and regulatory approvals during the eight-month long process of finalising the deal with Brazil. The EUA was received on ​June 4.

The company also maintained that it had neither received any advance payments nor did it suuply vaccine to Brazil. The company had followed a similar approach towards contracts, regulatory approvals and supplies in several countries worldwide, where Covaxin was being supplied successfully.

The pricing of Covaxin was between $15 and $20 per dose for supplies to other countries. The pricing for Brazil was also fixed at $15 per dose. Precisa Medicamentos was Bharat Biotech’s partner in Brazil. The partner is expected to assist, guide and support with regulatory submissions, licensure, distribution, insurance, conduct of phase III clinical trials, etc. Bharat Biotech followed a similar partnership model in all countries, where its vaccines are supplied, as it does not have its own offices in these countries.

Bharat Biotech and Precisa Medicamentos are conducting a 5,000 subject phase III clinical trial in Brazil, which was recently approved by ANVISA. The trial will be conducted by the Albert Einstein Institute.

Standard procurement process

Explaining the typical vaccine procurement process, the company stated that the procurement for Covid-19 vaccines and several vaccines for routine immunisation follow a common process which is widely accepted and established in the industry. Based on a country’s requirement, the company receives a letter of intent (or MoU) for procurement. The company then proceeds to apply for emergency use authorization (EUA) in the respective country.

Once EUA is received, the Ministry of Health (MoH) would proceed to place a firm order by releasing a purchase order, with the required initial quantities. In several countries, MoHs have placed orders for procurement prior to the approval of vaccines such as the USA, EU, India, etc. However, procurement happens only post EUA.

In order to secure a firm Purchase Order from the country, the company proceeds to raise a Pro Forma Invoice to the MOH, towards the supply of vaccine. Based on the invoice, the MOH pays the amount in advance. Once the payment is received, the company proceeds to supply the agreed quantities and within the agreed timelines.

Also read: Brazil suspends Bharat Biotech’s Covaxin order over graft allegations


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .

  • Follow Us :
  • Tags
  • Bharath Biotech
  • Brazil's President Jair Bolsonaro
  • Covaxin
  • Precisa Medicamentos

Related News

  • Telangana government to provide booster dose from April 19

    Telangana government to provide booster dose from April 19

  • Telangana’s Genome Valley nurtures startups into MNCs

    Telangana’s Genome Valley nurtures startups into MNCs

  • Covishield immune responses against Covid variants higher than Covaxin: Study

    Covishield immune responses against Covid variants higher than Covaxin: Study

  • Bharat Biotech, MoHFW deny rush, political pressure in regulatory approval for Covaxin

    Bharat Biotech, MoHFW deny rush, political pressure in regulatory approval for Covaxin

  • CORBEVAX booster shot approved for 18 years and above jabbed with Covaxin, Covishield

    CORBEVAX booster shot approved for 18 years and above jabbed with Covaxin, Covishield

  • ‘Covaxin safe, well-tolerated in paediatrics’

    ‘Covaxin safe, well-tolerated in paediatrics’

Latest News

  • India records 214 new COVID-19 cases on June 7

    34 seconds ago
  • Rupee rises 8 paise to 82.52 against US dollar

    16 mins ago
  • Delhi-Bhubaneswar Rajdhani Express narrowly escapes tragedy

    24 mins ago
  • Sensex climbs 235.1 points to 63,027.98 in early trade

    31 mins ago
  • WTC final: Virat Kohli lauds David Warner as ‘Impact Player’

    52 mins ago
  • Audio clip of Kalaburagi University lecturer harassing girl student goes viral

    1 hour ago
  • Birthday special: Shilpa Shetty’s notable performances

    1 hour ago
  • Techno Paints ropes in superstar Mahesh Babu as brand ambassador

    49 mins ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam